Elequin Capital’s Carter's CRI Stock Holding History

Elequin Capital’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-207	Closed	-$12.8K	–	400
2024 Q2	$12.8K	Buy	+207	New	+$14.4K	﹤0.01%	121

Other funds holding CRI

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elequin Capital's CRI Position: Q3 2024 in Review

Elequin Capital sold out of Carter's (CRI) in Q3 2024, closing a stake of 207 shares — an estimated $12.8K sold.

Elequin Capital first reported a position in CRI in Q2 2024 and held it in 1 quarter. The position peaked at $12.8K in Q2 2024. 329 funds tracked by Wall St. Rank hold CRI as of Q3 2024.

Elequin Capital reported no remaining Carter's position as of Q3 2024 after selling out during the quarter.
Elequin Capital sold 207 Carter's shares in Q3 2024, an estimated $12.8K.
Elequin Capital first reported a position in Carter's in Q2 2024 and held it in 1 quarter.
Elequin Capital's Carter's position peaked at $12.8K in Q2 2024.
329 funds tracked by Wall St. Rank held Carter's as of Q3 2024.

Based on Elequin Capital's 13F filing for Q3 2024, filed 14 Nov 2024.